Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Renal Cell Carcinoma × balstilimab × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 5 Neoplasm Metastasis 2 Stomach Neoplasms 1 Sarcoma 1 Resectable MMR-deficient Solid Tumors 1 Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) 1 Rectal Neoplasms 1 Pancreatic Cancer Metastatic 1 Oropharyngeal Neoplasms 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Cancer Metastatic 1 Advanced Renal Cell Carcinoma 1

Interventions

balstilimab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡